Srinidhi Fine-Chemicals and Narahari Belide Acquire Shares in Novelix Pharmaceuticals via Preferential Allotment
Srinidhi Fine-Chemicals LLP and Narahari Belide have increased their stake in Novelix Pharmaceuticals limited through the allotment of equity shares. The transaction involved the conversion of warrants into Equity Shares, which were issued under a Preferential Allotment to the company.The acquisition details pertain to Novelix Pharmaceuticals limited, with Srinidhi Fine-Chemicals LLP and Narahari Belide identified as the acquirers and persons acting in concert (PAC). The mode of acquisition for these shares was explicitly stated as "Conversion of warrants into Equity Shares issued on Preferential Allotment Basis."
Acquisition Details Overview
The transaction marked a material change in the shareholder structure of Novelix Pharmaceuticals. The details provided cover the holding status before the acquisition, the acquired instruments, and the resulting post-acquisition holdings for both Srinidhi Fine-Chemicals LLP and Narahari Belide.Key figures regarding the shareholding and capital base are presented below:
| Metric | Details Before Acquisition |
|---|---|
| Acquirer (Srinidhi Fine-Chemicals LLP) Holding | 79,02,000 shares (33.07% of total diluted share/voting capital) |
| Acquirer (Narahari Belide) Holding | Narahari Belide held a stake equivalent to 4.40% of the total diluted share/voting capital. |
| Total Warrants/Encumbrances Held by Acquirers | Srinidhi Fine-Chemicals LLP held 21,00,000 warrants. |
Shareholding Changes and Capital Structure Post Allotment
Following the acquisition on July 9, 2026, both acquiring parties saw an increase in their holdings as a direct result of the warrant conversion.The share capital and voting capital structure of Novelix Pharmaceuticals changed significantly post-acquisition:
| Metric | Before Acquisition | After Acquisition |
|---|---|---|
| Equity Share Capital | Rs 238,950,000 (comprising 23,895,000 Equity Shares of Rs.10/- each) | Rs 28,47,00,000 (comprising 28,470,000 Equity Shares of Rs.10/- each) |
| Total Diluted Share/Voting Capital | Rs 238,950,000 | Rs 28,47,00,000 |
The acquisition resulted in the company having a total diluted share/voting capital of Rs 28,47,00,000. The transaction was reported to have taken place on July 9, 2026.
Stock Price Movement
At the close of trading on Friday, shares of Novelix Pharmaceuticals Ltd settled at ₹66.50, registering a 0.31% decline. The stock experienced intraday volatility after moving between its low of ₹64.00 and high of ₹67.49.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.